Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,100
datasets available to search
ShareScore release 0.9.0
Dataset results
2,100 results for “75%”
Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test
ClinicalTrials.gov study NCT02963753. IPD Sharing: Not stated. Countries: 0. Publications: 0.
FIG. 75 in A checklist of bats (Mammalia: Chiroptera) from Lao PDR
FIG. 75. Distribution of Murina annamitica
FIGURE 75 in Quill mites (Acari: Syringophilidae) of the Palaearctic region 2840
FIGURE 75. Aulobia stachyris (Bochkov et al.) comb. nov., female. A, dorsal view; B, ventral view.
Thiuram treatment with 75 uM for 2 h
GEO Series GSE9326. Saccharomyces cerevisiae. 3 samples. Type: Expression profiling by array.
Figure 75 in Seven new peacock spiders from Western Australia and South Australia (Araneae: Salticidae: Euophryini: Maratus)
<p>Figure 75. Three views of the elevated position of a female Maratus tessellatus during a rejection display.</p>
Dataset related to article "Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study"
<p>This record contains raw data related to article "Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study"</p><p>Abstract</p><p><strong>Background: </strong>Glecaprevir and Pibrentasvir (G/P) determine high rates of sustained virological response (SVR) with optimal safety profile in patients with chronic hepatitis C virus (HCV) infection. The efficacy and safety of G/P in Caucasian patients aged 75 years and older have not been widely analysed.</p><p><strong>Methods: </strong>This is a retrospective multicentre real-world study enrolling all consecutive patients 75 years and older who received G/P between October 2017 and January 2022 at five referral centres in Italy. SVR was analysed by intention-to-treat (ITT) and per-protocol analyses (PP).</p><p><strong>Results: </strong>A total of 570 patients met the inclusion criteria and were analysed: mean age was 80 (75-97) years, 356 (62%) were females, 52% (298/570) had HCV-1, 44% (252/570) had HCV-2 and 137 (24%) patients had liver cirrhosis. Four hundred and sixty-three (81%) patients were taking at least one concomitant drug, with 144 (25%) taking ≥5 concomitant drugs. G/P was given for 8 weeks in 488 patients (86%). During treatment, 48 patients (8%) reported side effects, with 10 (2%) patients discontinuing treatment prematurely. Two patients developed treatment-unrelated serious adverse events. Overall, the SVR rate was 97.9% (558/570) by ITT analysis and 99.6% (558/560) by PP analysis. SVR rates remained consistently high among subgroup analysis stratified by genotype, treatment duration, fibrosis stage and concomitant medications.</p><p><strong>Conclusions: </strong>Treatment with G/P achieved 97.9% SVR rates in HCV patients older than 75 years of age. Safety was optimal with only 2% of patients discontinuing early.</p>
doi_dedup___::780f27fe86aef23e56c05c57007bf956
Open the record for dataset details and reuse information.
doi_dedup___::f4683fc47b2573e6dc89723ae4753abe
Open the record for dataset details and reuse information.
PDS Odyssey Radio Science Data (75)
RSS
Dataset 75
<p>dataset</p>
dedup_wf_002::38ff2b29baa94b34f2d6a716d3275f91
Open the record for dataset details and reuse information.
doi_________::1abde8d9f799a07186a3f26883b9cb02
Open the record for dataset details and reuse information.
doi_________::8d8e2dffce3ec9accabbd35bdfd23a87
Open the record for dataset details and reuse information.
doi_________::b4106c8b659bd0c375aab7443899b62c
Open the record for dataset details and reuse information.
doi_________::c68b2d5e120117e26c58d6ff1819ea2b
Open the record for dataset details and reuse information.
doi_________::ff13f610c8824b938d57ad0052f8f601
Open the record for dataset details and reuse information.
doi_dedup___::d94cde399fd5920e4149e3e850ac455f
Open the record for dataset details and reuse information.
r3730f562f9e::3493ac2fe39c726eccdd9a72621c8dc4
Open the record for dataset details and reuse information.
r3730f562f9e::ba8e92859efc9053c8c2ab30cb8986be
Open the record for dataset details and reuse information.
r3730f562f9e::da3f38226757134927cf95d815864bb9
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.